The Mast Cell: New Target in SpA?
Nilotinib shows biomarker, clinical benefits in peripheral spondyloarthritis
medpagetoday.com
A proof-of-concept study with the tyrosine kinase inhibitor nilotinib in spondyloarthritis
To evaluate the immunomodulating and clinical…
translational-medicine.biomedcentral.com